Skip to content

Pharminent

cropped-banner_frontpage_2026-07-11-2.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Commercial
  • The Rare Journey Needs a Special Pharmacy Partner
  • Commercial

The Rare Journey Needs a Special Pharmacy Partner

Drug Channels

Today's guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

CommercialRare DiseaseRead full story

pharminent March 27, 2026 (Last updated: March 30, 2026)

Drug Channels

Today’s guest post is from Bansi Nagji, Chief Executive Officer at PANTHERx Rare.

CommercialRare DiseaseRead full story

Sign up to receive free daily digest

Check your inbox or spam folder to confirm your subscription.

Post navigation

Previous: Merck’s deal for Terns sparks debate over a possible biotech bidding war
Next: Novartis targets Xolair successor in buyout of startup Excellergy

Related Stories

  • Commercial

Wegovy pill launches in UK as first daily oral GLP1 for weight management

pharminent July 6, 2026
  • Commercial

Tryngolza charts blockbuster course after FDA’s hypertriglyceridemia approval

pharminent June 26, 2026
  • Commercial

Lilly launches its LillyDirect sales channel in the UK

pharminent June 25, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.